Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Faeth Therapeutics Raises $25M Led by S2G Investments
Growth StageVenture Capital

Faeth Therapeutics Raises $25M Led by S2G Investments

•October 21, 2025
•Oct 21, 2025
0

Participants

Faeth Therapeutics

Faeth Therapeutics

company

Digitalisventures

Digitalisventures

investor

B Capital

B Capital

investor

S2G

S2G

investor

Khosla Ventures

Khosla Ventures

investor

KdT Ventures

KdT Ventures

investor

Avicella Capital

Avicella Capital

investor

Future Ventures

Future Ventures

investor

Cantos

Cantos

investor

Deal Summary

Faeth Therapeutics, a clinical-stage biotech focused on tumor metabolism, raised $25M in a financing round led by S2G Investments with participation from Khosla Ventures, Future Ventures, Digitalis Ventures, KdT Ventures, Cantos, B Capital Group and Avicella. The new capital brings Faeth's total funding to $92M.

0

Comments

Want to join the conversation?

Loading comments...